Authors: Gavrilov, D Kenzior, O Evans, M Calaluce, R Folk, WR

Citation: D. Gavrilov et al., Expression of urokinase plasminogen activator and receptor in conjunction with the ets family and AP-1 complex transcription factors in high grade prostate cancers, EUR J CANC, 37(8), 2001, pp. 1033-1040

Authors: Calaluce, R Kunkel, MW Watts, GS Schmelz, M Hao, JS Barrera, J Gleason-Guzman, M Isett, R Fitchmun, M Bowden, GT Cress, AE Futscher, BW Nagle, RB

Citation: R. Calaluce et al., Laminin-5-mediated gene expression in human prostate carcinoma cells, MOL CARCINO, 30(2), 2001, pp. 119-129

Authors: Hao, JS Jackson, L Calaluce, R McDaniel, K Dalkin, BL Nagle, RB

Citation: Js. Hao et al., Investigation into the mechanism of the loss of laminin 5 (alpha 3 beta 3 gamma 2) expression in prostate cancer, AM J PATH, 158(3), 2001, pp. 1129-1135

Authors: Calaluce, R Earnest, DL Heddens, D Einspahr, JG Roe, D Bogert, CL Marshall, JR Alberts, DS

Citation: R. Calaluce et al., Effects of piroxicam on prostaglandin E-2 levels in rectal mucosa of adenomatous polyp patients: A randomized phase IIb trial, CANC EPID B, 9(12), 2000, pp. 1287-1292

Authors: Scott, KM Fanta, P Calaluce, R Dalkin, B Weinstein, RS Nagle, RB

Citation: Km. Scott et al., Diagnostic frozen prostate sextant biopsies: An approach for preserving protein and RNA for additional studies, PROSTATE, 44(4), 2000, pp. 296-302